Latest Development Pipeline News

Optiscan Imaging Ltd has secured a $1.775 million R&D tax refund for FY24, more than doubling last year’s amount thanks to expanded claims on overseas research. The boost will fund ongoing development of its cutting-edge confocal laser endomicroscopy technology.

Paradigm Biopharmaceuticals has appointed Advanced Clinical as the Clinical Research Organisation for its critical Phase 3 trial targeting knee osteoarthritis pain, setting the stage for patient recruitment and dosing in Q2 2025.

Strike Energy has taken a final investment decision on its South Erregulla 85 MW peaking gas power station and confirmed significant gas discoveries at Erregulla Deep and Walyering East-1, positioning the company for growth amid a strategic leadership transition.

NewPeak Metals has acquired the Allaru Vanadium Project in Queensland, marking a strategic pivot into critical minerals, supported by a planned $2–3 million capital raise via rights issue.

Kuniko Limited's December 2024 quarterly report reveals a significant resource upgrade at its flagship Ertelien project, alongside promising copper-zinc targets in Trøndelag, reinforcing its role in Europe's sustainable battery metals supply chain.

Patrys Limited has halted plans for a Phase 1 trial of PAT-DX1 following disappointing GMP production results, pivoting its development efforts towards PAT-DX3 and exploring new partnerships.

Heavy Rare Earths Limited (ASX:HRE) advanced its uranium exploration footprint in South Australia with a key asset acquisition and bolstered its balance sheet through a $2.46 million capital raise during the December 2024 quarter.

Carnarvon Energy has announced a strategic on-market buy-back of up to 10% of its shares, signaling confidence despite the recent deferral of its Dorado Development Project.

I Synergy Group Limited has successfully completed a $100,000 private placement at a 16.67% discount, aiming to bolster its growth and working capital. The move signals investor confidence as the technology company advances its digital solutions agenda.

Algorae Pharmaceuticals reports robust progress in its drug development pipeline, highlighted by promising preclinical results for cardiovascular and dementia candidates and significant AI platform enhancements.

Brightstar Resources has initiated ore haulage from its Laverton Hub under a key Ore Purchase Agreement, setting the stage for its first gold pour in March 2025 and positioning the company for growth amid record gold prices.

Peregrine Gold secures a significant $1 million commitment from its largest shareholder, Yandal Investments, strengthening its entitlement offer ahead of the project sale to Capricorn Metals.